Evidence map›Paper›PMID 25817226›Full record

Trial reportNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2015

Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK).

Teresa K Chen, Michelle M Estrella, Brad C Astor, Tom Greene, Xuelei Wang, Morgan E Grams, Lawrence J Appel

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Teresa K ChenDivision of Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Michelle M EstrellaDivision of Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD, USA Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD, USA.
Brad C AstorDivision of Nephrology, University of Wisconsin School of Medicine, Madison, WI, USA.
Tom GreeneDivision of Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA.
Xuelei WangCenter for Clinical Investigation, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Morgan E GramsDivision of Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD, USA Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD, USA.
Lawrence J AppelWelch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD, USA.
Johns Hopkins Medicine · USJohns Hopkins University · USUniversity of Utah · USUniversity of Wisconsin–Madison · USUniversity School · US

Funding

ZOVIRAX CREAM TO TREAT HERPES LABIALIS IN ADOLESCENTSM01RR000827 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHANG, R JEFFREY · 1985 to 2010
$74.3M
ZIPRASIDONE (GEODON) AUGMENTATION IN SEROTONIN REUPTAKE INHIBITOR-RESISTANT OBM01RR000071 · NCRR · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI NEWCORN, JEFFREY H · 1985 to 2009
$41.5M
ZINC AND CA EDTA THERAPY OF PLUMBISMM01RR000052 · NCRR · JOHNS HOPKINS UNIVERSITY · PI BELCHER, HAROLYN MILLICENT EDITH · 1985 to 2007
$37.3M
Zosuquidar trihydrochloride for acute myeloid leukemia &refractory anemiaM01RR000080 · NCRR · UNIVERSITY HOSPITALS OF CLEVELAND · PI DAVIS, PAMELA B · 1985 to 2007
$22.2M
MOUNT SINAI INSTITUTES FOR CLINICAL AND TRANSLATIONAL SCIENCESUL1RR029887 · NCRR · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SAMPSON, HUGH A · 2009 to 2011
$19.2M
YQ MICRODELETIONS AND MALE INFERTILITYP20RR011145 · NCRR · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI NORRIS, KEITH C · 1995 to 2009
$17.0M
WARCEFP20RR011104 · NCRR · MOREHOUSE SCHOOL OF MEDICINE · PI MENG, YUAN-XIANG · 1995 to 2009
$14.5M
RENAL DISEASE EPIDEMIOLOGY TRAINING GRANTT32DK007732 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI CREWS, DEIDRA CANDICE · 1995 to 2024
$7.7M
MENTORING PROGRAM FOR CLINICAL RESEARCHERS IN NEPHROLOGYK24DK002818 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2001 to 2010
$1.5M
Burden of Chronic Kidney Disease in HIV InfectionK23DK081317 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI ESTRELLA, MICHELLE M · 2009 to 2013
$835k
Endogenous Cardiac Glycosides in AASKR21DK078218 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI ASTOR, BRAD C · 2009 to 2010
$320k
NCRR NIH HHS 2P20 RR11104NCRR NIH HHS M01 RR000052NCRR NIH HHS M01 RR000071NCRR NIH HHS M01 RR000080NCRR NIH HHS M01 RR00052NCRR NIH HHS M01 RR-00071NCRR NIH HHS M01 RR-00080NCRR NIH HHS M01 RR000827NCRR NIH HHS M01 RR00827NCRR NIH HHS P20 RR011104NCRR NIH HHS P20 RR011145NCRR NIH HHS P20-RR11145NCRR NIH HHS RR029887NCRR NIH HHS UL1 RR029887NIDDK NIH HHS 1K23DK081317NIDDK NIH HHS 5T32DK007732NIDDK NIH HHS DK 2818-02NIDDK NIH HHS K23 DK081317NIDDK NIH HHS K24 DK002818NIDDK NIH HHS R21 DK078218NIDDK NIH HHS R21DK078218NIDDK NIH HHS T32 DK007732PHS HHS M0100032
6 · The paper itself

Abstract

backgroundAnemia is common in chronic kidney disease (CKD) and associated with poor outcomes. In cross-sectional studies, lower estimated glomerular filtration rate (eGFR) has been associated with increased risk for anemia. The aim of this study was to determine how hematocrit changes as eGFR declines and what factors impact this longitudinal association.

methodsWe followed 1094 African-Americans with hypertensive nephropathy who participated in the African-American Study of Kidney Disease and Hypertension. Mixed effects models were used to determine longitudinal change in hematocrit as a function of eGFR. Interaction terms were used to assess for differential effects of age, gender, baseline eGFR, baseline proteinuria, malnutrition and inflammation on eGFR-associated declines in hematocrit. In sensitivity analyses, models were run using iGFR (by renal clearance of I(125) iothalamate) in place of eGFR.

resultsAt baseline, mean hematocrit was 39% and 441 (40%) individuals had anemia. The longitudinal relationship between eGFR and hematocrit differed by baseline eGFR and was steeper when baseline eGFR was <45 mL/min/1.73 m(2). For example, the absolute decline in hematocrit per 10 mL/min/1.73 m(2) decline in longitudinal eGFR was -3.7, -1.3 and -0.5% for baseline eGFR values of 20, 40 and 60 mL/min/1.73 m(2), respectively (P < 0.001 comparing the longitudinal association between baseline eGFR = 40 or 60 versus baseline eGFR = 20 mL/min/1.73 m(2)). Similarly, male sex, younger age (<65 years) and higher baseline proteinuria (protein-to-creatinine ratio >0.22) were associated with greater hematocrit declines per unit decrease in longitudinal eGFR compared with female sex, older age and low baseline proteinuria, respectively (P-interaction <0.05 for each comparison). The longitudinal eGFR-hematocrit association did not differ by body mass index, serum albumin or C-reactive protein.

conclusionsMen, younger individuals and those with low baseline eGFR (<45 mL/min/1.73 m(2)) or baseline proteinuria are particularly at risk for eGFR-related declines in hematocrit.

Indexed as

Glomerular Filtration RateHematocritAdolescentAdultAgedAnemiaBlack or African AmericanBody Mass IndexC-Reactive ProteinCross-Sectional StudiesFemaleHumansHypertensionHypertension, RenalIothalamic AcidKidney Function TestsC-Reactive ProteinIothalamic AcidAfrican-American Study of Kidney Disease and Hypertension (AASK)anemiachronic kidney diseasehematocrit

Identifiers

PMID25817226
PMCPMC4513895
OpenAlexW2158947138

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.